Page last updated: 2024-08-05 10:54:40
propane-1,2-diols
null
ChEBI ID: 26284
Members (5)
Member | Definition | Role |
---|---|---|
chlorphenesin | Glycerol in which the hydrogen of one of the primary hydroxy groups is substituted by a 4-chlorophenyl group. It has antifungal and antibacterial properties, and is used for treatment of cutaneous and vaginal infections. Its 1-carbamate is used as a skeletal muscle relaxant for the treatment of painful muscle spasm. | chlorphenesin |
dyphylline | An oxopurine that is theophylline bearing a 2,3-dihydroxypropyl group at the 7 position. It has broncho- and vasodilator properties, and is used in the treatment of asthma, cardiac dyspnea, and bronchitis. It is also an ingredient in preparations that have been promoted for coughs. | dyphylline |
pd 0325901 | A hydroxamic acid ester that is benzhydroxamic acid (N-hydroxybenzamide) in which the hydroxamic acid group has been converted to the corresponding 2,3-dihydroxypropyl ester and in which the benzene ring has been substituted at position 2 by a (2-fluoro-4-iodophenyl)amino group and at positions 3 and 4 by fluorines (the R enantiomer). | PD 0325901 |
propylene glycol | The simplest member of the class of propane-1,2-diols, consisting of propane in which a hydrogen at position 1 and a hydrogen at position 2 are substituted by hydroxy groups. A colourless, viscous, hygroscopic, low-melting (-59degreeC) and high-boiling (188degreeC) liquid with low toxicity, it is used as a solvent, emulsifying agent, and antifreeze. | propane-1,2-diol |
thioglycerol | A thiol that is glycerol in which one of the primary hydroxy groups is replaced by a thiol group. | monothioglycerol |
Research
Studies (2,635)
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 467 (17.72) | 18.7374 |
1990's | 329 (12.49) | 18.2507 |
2000's | 610 (23.15) | 29.6817 |
2010's | 954 (36.20) | 24.3611 |
2020's | 275 (10.44) | 2.80 |
Study Types
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 126 (4.45%) | 5.53% |
Reviews | 88 (3.11%) | 6.00% |
Case Studies | 122 (4.31%) | 4.05% |
Observational | 2 (0.07%) | 0.25% |
Other | 2,493 (88.06%) | 84.16% |